0000000000908097

AUTHOR

Anna Di Prima

showing 36 related works from this author

Systemic Immune Responses in Alzheimer's Disease: In Vitro Mononuclear Cell Activation and Cytokine Production

2010

To investigate the systemic signs of immune-inflammatory responses in Alzheimer's disease (AD), in the present study we have analyzed blood lymphocyte subsets and the expression of activation markers on peripheral blood mononuclear cells (PBMCs) from AD patients and age-matched healthy controls (HC) activated in vitro by recombinant amyloid-beta peptide (rAbeta42). Our study of AD lymphocyte subpopulations confirms the already described decrease of the absolute number and percentage of B cells when compared to HC lymphocytes, whereas the other subsets are not significantly different in patients and controls. We report the increased expression of the activation marker CD69 and of the chemoki…

MaleEotaxinCCR2ChemokineTime Factorsmedicine.medical_treatmentPeripheral blood mononuclear cellChemokine receptorImmune systemAlzheimer’s disease chemokine cytokine PBMC rAβ42Alzheimer DiseasemedicineHumansLymphocytesIL-2 receptorCells CulturedAgedSettore MED/04 - Patologia GeneraleAged 80 and overAnalysis of VarianceAmyloid beta-Peptidesbiologybusiness.industryGeneral NeuroscienceGeneral MedicineMiddle AgedFlow CytometryPeptide FragmentsPsychiatry and Mental healthClinical PsychologyCytokineGene Expression RegulationCase-Control StudiesImmunologyLeukocytes Mononuclearbiology.proteinCytokinesFemaleGeriatrics and GerontologybusinessJournal of Alzheimer's Disease
researchProduct

Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD).

2009

Acetylcholinesterase inhibitors (AchEIs) are extensively used in Alzheimer's disease (AD) while reality orientation therapy (ROT) is a cognitive rehabilitation indicated for mentally deteriorated patients. We aimed to evaluate the efficacy of the combination of donepezil with an intensive ROT with active participation of the caregiver. Patients with AD (n=100, mean age 78.4±4.3 years) initiated treatment with donepezil, 5mg/day; 62 of them underwent a 3-week, daily ROT and physical reactivation training with the caregiver (Group A); 38 participants received only donepezil therapy (Group B). All subjects were tested for cognitive and functional abilities at baseline, at the end of the traini…

MaleAgingmedicine.medical_specialtyHealth (social science)Diseasechemistry.chemical_compoundPiperidinesAlzheimer Diseasemental disordersmedicineDementiaHumansDonepezilCognitive rehabilitation therapyDonepezilAgedAged 80 and overPsychiatric Status Rating ScalesAnalysis of VarianceChi-Square DistributionCognitive Behavioral TherapyCognitionmedicine.diseaseAcetylcholinesteraseActive participationTreatment OutcomechemistryIndansPhysical therapyFemaleCholinesterase InhibitorsGeriatrics and GerontologyTraining programPsychologyGerontologymedicine.drugArchives of gerontology and geriatrics
researchProduct

LA DOMOTICA A FAVORE DEGLI ANZIANI

2008

DOMOTICA ANZIANO
researchProduct

I LUOGHI DELLA CURA E DEL MORIRE: REPARTO DI GERIATRIA: TRE ANNI DI ATTIVITÀ

2006

researchProduct

MILD COGNITIVE IMPAIRMENT (MCI): LA ZONA GRIGIA

2008

MCI ANZIANO DEFICIT COGNITIVO
researchProduct

Ruolo del gene PNPLA3 nella suscettibilità genetica della suscettibilità genetica della steatosi epatica

Settore MED/09 - Medicina Internagene PNPLA3
researchProduct

RIABILITAZIONE NEUROMOTORIA NELLA M. DI PARKINSON: CONDIZIONAMENTO SENSORIALE

2006

researchProduct

MALATTIA DI PARKINSON: FATTORI AMBIENTALI E GENETICI

2007

researchProduct

TORRE DI LONDRA: DEMENZA FRONTO-TEMPORALE E DISTURBO DELL’ UMORE

2008

DEMENZA ANZIANO UMORE
researchProduct

PSEUDODEMENZA, DEPRESSIONE E DEMENZA

2008

DEMENZA DEPRESSIONE ANZIANO
researchProduct

DEPRESSIONE, ANZIANI E PSICOTERAPIA

2007

researchProduct

NECESSITÀ DEL RICOVERO IN RSA IN ALCUNI PAZIENTI CON DEMENZA DI ALZHEIMER. CASO CLINICO

2008

RSA ANZIANO DEMENZA
researchProduct

CORRELAZIONE TRA DEMENZA E DEPRESSIONE. Studio su 60 pazienti ambulatoriali

2007

researchProduct

Variations in the volatile compounds of a Fennel (Foeniculum vulgare Mill.) variety grown in a semi-arid Mediterranean environment

2005

Fennel is an industrial source of anethole but, recently, further interest has came from the suggested possibility of many industrial uses of this plant. The volatile substances from the seeds of fennel grown in Sparacia (Cammarata - AG - Sicily; 37° 38' N; 13° 46' E) have been investigated and compared on a statistical base with previously reported data. The variety grown in Sparacia fall into the "high fenchone" chemovariety. The substances alpha-toluene, alpha-terpinene, beta-phellandrene + limonene and camphene appear the components most sensitive to environment and grow condition modifications. Fennel is an industrial source of anethole but, recently, further interest has come from the…

Settore AGR/13 - Chimica Agrariavolatile compounds fennel SPME GCMS anetholeSettore AGR/02 - Agronomia E Coltivazioni Erbacee
researchProduct

DEFICIT COGNITIVO E DIABETE. STUDIO OSSERVAZIONALE

2008

DEFICIT COGNITIVODIABETE anziano
researchProduct

MILD COGNITIVE IMPAIRMENT: LA ZONA GRIGIA

2008

MILD COGNITIVE IMPAIRMENT DEMENZA
researchProduct

ATTUALE APPROCCIO TERAPEUTICO NEI PAZIENTI CON MALATTIA DI ALZHEIMER

2007

researchProduct

DISTURBI DEL SONNO IN SOGGETTI ANZIANI

2008

SONNO ANZIANO
researchProduct

DEPRESSIONE E RISCHIO DI EVENTI CEREBROVASCOLARI ACUTI

2008

depressione ictus anziano
researchProduct

TEST-AND-TREAT ANCHE PER LA POPOLAZIONE GERIATRICA CON HP-INFEZIONE?

2008

helicobacter pylori HP-infezione test and treat
researchProduct

DOMOTICA, UTENZA DEBOLE E ANZIANI

2007

researchProduct

MALATTIA DI ALZHEIMER: PREDISPOSIZIONE, PREVENZIONE E TERAPIE FARMACOLOGICHE

2008

MALATTIA DI ALZHEIMER PREDISPOSIZIONE PREVENZIONE
researchProduct

CO-MORBILITA’ E DEPRESSIONE NELL’ANZIANO

2006

researchProduct

L’ALIMENTAZIONE NEI PAZIENTI ISTITUZIONALIZZANTI AFFETTI DA DEMENZA TIPO ALZHEIMER

2008

DEMENZA ALIMENTAZIONE ANZIANO
researchProduct

MALATTIA DI ALZHEIMER: PREDISPOSIZONE, PREVENZIONE E TERAPIE FARMACOLOGICHE

2008

MALATTIA DI ALZHEIMER anziano
researchProduct

COENZIMA Q E MALATTIA DI PARKINSON

2008

M. di Parkinson coenzima Q
researchProduct

DEMENZA E DISTURBI DELL’ALIMENTAZIONE

2007

researchProduct

NECESSITÀ DI UNA PERIODICA ASSISTENZA GERIATRICA DOMICILIARE. DESCRIZIONE DI UN CASO CLINICO

2007

researchProduct

DEMENZE E RISCHIO DI FRATTURE OSTEOPOROTICHE NEGLI ANZIANI. STUDIO OSSERVAZIONALE IN UN’UNITA’ VALUTATIVA ALZHEIMER (n°6) DI PALERMO

2008

DEMENZE FRATTURE OSTEOPOROTICHE ANZIANI
researchProduct

DEPRESSIONE E DEMENZA: STUDIO NEUROPSICOLOGICO

2006

researchProduct

SINTOMI COGNITIVI E DEPRESSIVI IN SOGGETTI NON DEMENTI CON MALATTIA CEREBROVASCOLARE SOTTOCORTICALE

2007

researchProduct

PARKINSON E DEMENZA : VALUTAZIONE COMPARATIVA TRA INDICI NEUROPSICOLOGICI E NEURORADIOLOGICI

2007

researchProduct

Celiac disease: a cause of unexplained elevated serum pancreatic enzymes

2005

researchProduct

HOSPICE E TERMINALITÀ IN PAZIENTI CON DEMENZA

2006

researchProduct

TERAPIE DI RIABILITAZIONE COGNITIVA NEL COMPLESSO PARKINSON-DEMENZA NELL’ANZIANO. Caso clinico

2007

researchProduct

DISTURBI D’ANSIA NELL’ANZIANO

2007

researchProduct